Part,  Chapter, Paragraph

 1   II,     9        |            to supplement congenital anomaly registers to determine numbers.
 2   II,     9        |      individual cases of congenital anomaly, the cause of the condition
 3   II,     9        |   delivering babies with congenital anomaly due to chronic disease status.
 4   II,     9        |   associated with higher congenital anomaly risk (EUROCAT, 2004; Macintosh
 5   II,     9        |          carry a risk of congenital anomaly when taken during pregnancy.~ ~
 6   II,     9        |         level of risk of congenital anomaly associated with ART (Hansen
 7   II,     9.  1.  2|     surveillance through congenital anomaly registers, and the focus
 8   II,     9.  1.  2|           be included in congenital anomaly registers, but are not included
 9   II,     9.  1.  2|         population-based congenital anomaly registers, using multiple
10   II,     9.  1.  2| terminations of pregnancy for fetal anomaly (TOPFA) following prenatal
11   II,     9.  1.  2|    different severities of the same anomaly. Data quality can also be
12   II,     9.  1.  2|          with no current congenital anomaly registers. The data are
13   II,     9.  1.  2|        regard to type of congenital anomaly. Differences between countries
14   II,     9.  1.  2|         mortality due to congenital anomaly can reflect one or more
15   II,     9.  1.  2|            affected by a congenital anomaly in that country b) the level
16   II,     9.  1.  2|      livebirth where the congenital anomaly is so severe that the baby
17   II,     9.  1.  2|       across years. Many congenital anomaly registers nevertheless now
18   II,     9.  1.  2|             pregnancy due to foetal anomaly (TOPFA) following prenatal
19   II,     9.  1.  2|        births of EUROCAT congenital anomaly subgroups 2000-2004~ ~The
20   II,     9.  1.  2|            defect and a chromosomal anomaly is recorded only under chromosomal
21   II,     9.  1.  2|             subgroups of congenital anomaly, available on its website (
22   II,     9.  1.  2|             of pregnancy for foetal anomaly (TOPFA), live-birth prevalence
23   II,     9.  1.  2|         stillbirths with congenital anomaly is 0.43 per 1 000 births,
24   II,     9.  1.  2|            associated to congenital anomaly of 0.99 per 1 000 births (
25   II,     9.  1.  2|             2). The main congenital anomaly subgroups contributing to
26   II,     9.  1.  2|            of perinatal deaths with anomaly), nervous system anomalies (
27   II,     9.  1.  2|            of perinatal deaths with anomaly), and chromosomal anomalies (
28   II,     9.  1.  2|         mortality due to congenital anomaly varies per country (Table
29   II,     9.  1.  2|            associated to congenital anomaly are recorded in Ireland (
30   II,     9.  1.  2|            lethal or high mortality anomaly which would have been prenatally
31   II,     9.  1.  2|             of Pregnancy for Foetal Anomaly following prenatal diagnosis (
32   II,     9.  1.  2|         done only in case of lethal anomaly. Some countries allow TOPFA
33   II,     9.  1.  2|     neonatal deaths with congenital anomaly (Table 9.1.2.3). Up to 0.
34   II,     9.  1.  2|            presence of a congenital anomaly, whether as a TOPFA, stillbirth
35   II,     9.  1.  2|          consequences of congenital anomaly, the vast majority of cases
36   II,     9.  1.  2|     majority of cases of congenital anomaly across Europe are live born
37   II,     9.  1.  2| Gastroschisis~ ~Gastroschisis is an anomaly of the abdominal wall, with
38   II,     9.  1.  2|            to supplement congenital anomaly registers to determine numbers.
39   II,     9.  1.  2|      individual cases of congenital anomaly, the cause of the condition
40   II,     9.  1.  2|   delivering babies with congenital anomaly due to chronic disease status.
41   II,     9.  1.  2|   associated with higher congenital anomaly risk (EUROCAT, 2004; Macintosh
42   II,     9.  1.  2|          carry a risk of congenital anomaly when taken during pregnancy.~ ~
43   II,     9.  1.  2|         level of risk of congenital anomaly associated with ART (Hansen
44   II,     9.  1.  2|           differences in congenital anomaly risk at European level,
45   II,     9.  1.  2|         risk factors for congenital anomaly such as maternal nutrition,
46   II,     9.  1.  2|           help to reduce congenital anomaly risk, as well as specific
47   II,     9.  1.  2|          the likely outcome for the anomaly which has been diagnosed,
48   II,     9.  1.  2|           being spent on congenital anomaly registers by European Union
49   II,     9.  1.  2|    increasing success in congenital anomaly prevention, as evidenced
50   II,     9.  1.  2|  Inequalities in Risk of Congenital Anomaly”, Arch Dis Childh, Vol 82,
51   II,     9.  1.  2|             of Pregnancy for Foetal Anomaly~ ~
52  Key,   Ap5.  0.  0|             angiosarcomas~anomalies~anomaly~anorexia~anthrax~antibiotic~